Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2018 Apr 19;19(1):121.
doi: 10.1186/s12891-018-2047-1.

Controlled, cross-sectional, multi-center study of physical capacity and associated factors in women with fibromyalgia

Anette Larsson  1   2 , Annie Palstam  3 , Jan Bjersing  4 , Monika Löfgren  5 , Malin Ernberg  6 , Eva Kosek  7 , Björn Gerdle  8 , Kaisa Mannerkorpi  9   10   4
Affiliations
Controlled Clinical Trial

Controlled, cross-sectional, multi-center study of physical capacity and associated factors in women with fibromyalgia

Anette Larsson et al. BMC Musculoskelet Disord. .

Abstract

Background: Health and physical capacity are commonly associated with disease, age, and socioeconomic factors. The primary objective of this study was to investigate the degree to which physical capacity, defined as muscle strength and walking ability, is decreased in women with fibromyalgia (FM), as compared to healthy women, who are matched for age and level of education. The secondary aim was to investigate whether muscle strength and walking ability are associated with age, symptom duration, activity limitations and, Body Mass Index (BMI) in women with FM and control subjects.

Methods: This controlled, cross-sectional, multi-center study comprised 118 women with FM and 93 age- and education-level-matched healthy women. The outcome measures were isometric knee-extension force, isometric elbow-flexion force, isometric hand-grip force, and walking ability. Differences between the groups were calculated, and for the women with FM analyses of correlations between the measures of physical capacity and variables were performed.

Results: The women with FM showed 20% (p < 0.001) lower isometric knee-extension force, 36% (p < 0.001) lower isometric elbow-flexion force, 34% (p < 0.001) lower isometric hand-grip force, and 16% lower walking ability (p < 0.001), as compared to the healthy controls. All measures of muscle strength in women with FM showed significant weak to moderate relationship to symptom duration (rs = - 0.23-0.32) and walking ability (rs = 0.25-0.36). Isometric knee-extension force correlated with activity limitations, as measured using the SF-36 Physical function subscale (rs=0.23, p = 0.011).

Conclusions: Physical capacity was considerably decreased in the women with FM, as compared to the age- and education-level-matched control group. All measures of physical capacity showed a significant association with symptom duration. Knee-extension force and walking ability were significantly associated with activity limitations, age, and BMI. It seems important to address this problem and to target interventions to prevent decline in muscle strength. Assessments of muscle strength and walking ability are easy to administer and should be routinely carried out in the clinical setting for women with FM.

Trial registration: ClinicalTrials.gov identification number: NCT01226784 , Oct 21, 2010.

Keywords: Activity limitations; Fibromyalgia; Muscle strength; Physical capacity; Symptom duration; Walking ability.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The study was conducted in accordance with the Declaration of Helsinki, with approval for all sites i.e. Gothenburg, Stockholm and Linköping, from the Regional Ethics Committee at Karolinska Institute in Stockholm (2010/1121–31/3). All the participants were given written and oral information and written consent was obtained.

Competing interests

The authors declare that they have no competing interests. No financial conflicts of interest are declared for any of the authors.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Gran JT. The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol. 2003;17(4):547–561. doi: 10.1016/S1521-6942(03)00042-1. - DOI - PubMed
    1. Lindell L, Bergman S, Petersson IF, Jacobsson LT, Herrstrom P. Prevalence of fibromyalgia and chronic widespread pain. Scand J Prim Health Care. 2000;18(3):149–153. doi: 10.1080/028134300453340. - DOI - PubMed
    1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 1990;33(2):160–172. doi: 10.1002/art.1780330203. - DOI - PubMed
    1. Mannerkorpi K, Burckhardt CS, Bjelle A. Physical performance characteristics of women with fibromyalgia. Arthritis Care Res. 1994;7(3):123–129. doi: 10.1002/art.1790070305. - DOI - PubMed
    1. Henriksen M, Lund H, Christensen R, Jespersen A, Dreyer L, Bennett RM, Danneskiold-Samsoe B, Bliddal H. Relationships between the fibromyalgia impact questionnaire, tender point count, and muscle strength in female patients with fibromyalgia: a cohort study. Arthritis Rheum. 2009;61(6):732–739. doi: 10.1002/art.24512. - DOI - PubMed

Publication types

Associated data